MENU
+Compare
HIMZ
ETF ticker: NASDAQ
AS OF
Aug 29, 12:33 PM (EDT)
Price
$13.98
Change
-$0.70 (-4.77%)

HIMZ Defiance Daily Target 2X Long HIMS ETF Forecast, Technical & Fundamental Analysis

The investment seeks daily investment results, before fees and expenses, of two times (200%) the daily percentage change in the share price of Hims & Hers Health Inc... Show more

Category: #Trading
HIMZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HIMZ with price predictions
Aug 28, 2025

Momentum Indicator for HIMZ turns negative, indicating new downward trend

HIMZ saw its Momentum Indicator move below the 0 level on August 06, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 3 similar instances where the indicator turned negative. In of the 3 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HIMZ turned negative on August 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 2 similar instances when the indicator turned negative. In of the 2 cases the stock turned lower in the days that followed. This puts the odds of success at .

HIMZ moved below its 50-day moving average on August 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIMZ crossed bearishly below the 50-day moving average on August 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 1 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIMZ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HIMZ broke above its upper Bollinger Band on July 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for HIMZ entered a downward trend on August 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HIMZ's RSI Indicator exited the oversold zone, of 1 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 5 cases where HIMZ's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIMZ advanced for three days, in of 23 cases, the price rose further within the following month. The odds of a continued upward trend are .

View a ticker or compare two or three
HIMZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIVK0.740.05
+6.68%
Vivakor
SE186.243.33
+1.82%
Sea Limited
BRFS3.690.01
+0.27%
BRF - Brasil Foods SA
FINW19.470.02
+0.10%
FinWise Bancorp
ELVN20.36-0.32
-1.55%
Enliven Therapeutics